Hydrofarm regains Nasdaq equity compliance after eliminating $109 million term loan

Hydrofarm Holdings Group, a controlled-environment agriculture supplier and not a pharma company, said Nasdaq confirmed by letter dated November 9, 2026 that it again meets the $2.5 million minimum stockholders' equity rule. The confirmation followed the October 27 termination of its $109 million term loan, a registered direct offering and a concurrent private placement. The company still has to meet the minimum bid price requirement and remains under a mandatory panel monitor.

12 Nov 2026 · Hydrofarm Holdings Group, Inc. HYFM · Company news

Company's press release (SEC filing): Hydrofarm Holdings Group, Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →

Financing

Hydrofarm regains Nasdaq equity compliance after eliminating $109 million term loan

IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M

Femasys Q3 2026: $30M private placement closed; U.S. sales flat, total sales fall 44.5% to $404,597

Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants

Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities

Windward Bio prices Nasdaq IPO of 10.3 million shares at $17, targeting $225 million in gross proceeds

Lichen International prices $3.5M registered direct offering of units with warrants on Nasdaq